These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33220816)

  • 21. Overactive bladder symptoms after midurethral sling surgery in women: Risk factors and management.
    Marcelissen T; Van Kerrebroeck P
    Neurourol Urodyn; 2018 Jan; 37(1):83-88. PubMed ID: 28631830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urodynamic findings in women with refractory overactive bladder symptoms.
    Al-Zahrani AA; Gajewski J
    Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Useful parameters to predict the presence of detrusor overactivity in male patients with lower urinary tract symptoms.
    Matsukawa Y; Majima T; Ishida S; Funahashi Y; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Jun; 39(5):1394-1400. PubMed ID: 32259358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can we predict which patients will experience resolution of detrusor overactivity after transurethral resection of the prostate?
    Antunes AA; Iscaife A; Reis ST; Albertini A; Nunes MA; Lucon AM; Nahas WC; Srougi M
    J Urol; 2015 Jun; 193(6):2028-32. PubMed ID: 25583645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment.
    Thiruchelvam N; Cruz F; Kirby M; Tubaro A; Chapple CR; Sievert KD
    BJU Int; 2015 Dec; 116(6):853-61. PubMed ID: 25684118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The practical update for family physicians in the diagnosis and management of overactive bladder and lower urinary tract symptoms.
    Barkin J; Habert J; Wong A; Lee LYT
    Can J Urol; 2017 Oct; 24(5S1):1-11. PubMed ID: 29151006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Overactive Bladder Symptoms After Radical Prostatectomy.
    Peyronnet B; Brucker BM
    Curr Urol Rep; 2018 Oct; 19(12):95. PubMed ID: 30306278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
    Lee JY; Kim HW; Lee SJ; Koh JS; Suh HJ; Chancellor MB
    BJU Int; 2004 Oct; 94(6):817-20. PubMed ID: 15476515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study.
    Kwon O; Lee HE; Bae J; Oh JK; Oh SJ
    Urology; 2014 Mar; 83(3):581-5. PubMed ID: 24373317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and treatment of lower urinary tract symptoms suggestive of overactive bladder and bladder outlet obstruction among men in general practice in the UK.
    Morant SV; Reilly K; Bloomfield GA; Chapple C
    Int J Clin Pract; 2008 May; 62(5):688-94. PubMed ID: 18355237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of holmium laser enucleation of the prostate (HoLEP) in men with bladder outlet obstruction (BOO) and non-neurogenic bladder dysfunction.
    Pyun JH; Kang SG; Kang SH; Cheon J; Kim JJ; Lee JG
    Kaohsiung J Med Sci; 2017 Sep; 33(9):458-463. PubMed ID: 28865604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interrelation of hyperactivity of bladder and infravesical obstruction in patients with benign prostate hyperplasia].
    Bablumyan A
    Georgian Med News; 2010 Dec; (189):7-11. PubMed ID: 21252402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of mesh pelvic floor reconstructive surgery on OAB symptoms].
    Nowakowski L; Wróbel A; Jankiewicz K; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2014 Oct; 85(10):760-4. PubMed ID: 25546927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive Factors of De Novo Overactive Bladder After Artificial Urinary Sphincter Implantation in Men With Postprostatectomy Incontinence.
    Ko KJ; Lee CU; Kim TH; Suh YS; Lee KS
    Urology; 2018 Mar; 113():215-219. PubMed ID: 29030076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy.
    Matsukawa Y; Yoshino Y; Ishida S; Fujita T; Majima T; Funahashi Y; Sassa N; Kato M; Gotoh M
    Neurourol Urodyn; 2018 Aug; 37(6):2008-2014. PubMed ID: 29635709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
    Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O
    Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for persistent, de novo and overall overactive bladder syndrome after surgical prolapse repair.
    Frigerio M; Manodoro S; Cola A; Palmieri S; Spelzini F; Milani R
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():141-145. PubMed ID: 30597338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.